Breaking News, Collaborations & Alliances

Lilly Expands Novast Pact in China

Novast to supply Lilly-branded generic medicines

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Eli Lilly and Co. has increased its network of manufacturing capabilities in China by expanding its collaboration with Novast Laboratories, a generic and specialty pharmaceutical company based in Nantong, China. Through the collaboration, Lilly plans to build a portfolio of branded generic drugs in China. Novast may also provide local and regional manufacturing capabilities for Lilly’s development pipeline of potential new medicines.   Lilly will increase its equity in Novast by $20 millio...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters